- Microdosing can positively influence emotional regulation and reduce ADHD symptoms in adults with severe symptoms, particularly improving expressive suppression.
- Improvements in cognitive reappraisal and empathy observed after microdosing were not sustained over time when compared to those using conventional medications.
- The study’s findings suggest that microdosing may not significantly enhance empathy, indicating a need for further research on this aspect in affected populations.
Study Overview
This prospective study involves 233 individuals with severe ADHD symptoms who practiced microdosing (MD), aiming to assess its effects on emotional regulation (ER) and empathy. Results indicated initial enhancements in specific areas of ER and empathy during the microdosing period, particularly in cognitive reappraisal, expressive suppression, perspective-taking, and personal distress. Notably, when compared to a group solely using conventional medications, only the benefits related to expressive suppression remained after four weeks, while improvements in cognitive reappraisal and empathy faded.
Understanding ADHD and Microdosing
Attention deficit hyperactivity disorder (ADHD) is marked by challenges in attention, hyperactivity, and impulse control, alongside difficulties in emotional regulation. Traditional medications are often effective for core symptoms of ADHD but may not sufficiently address problems related to emotional and social functioning. As a result, alternative treatments such as psychedelic microdosing have gained attention for their potential benefits on emotional processing, especially for those with severe ADHD symptoms. While previous studies have shown social and emotional advantages from psychedelic substances, fewer have examined their specific impact on ER and empathy in adults with these symptoms.
Methodology of the Studies
In the first study, the researchers assessed the changes in ER and empathy among participants diagnosed with ADHD or experiencing severe symptoms over a four-week period of self-initiated microdosing. Participants provided consent and completed surveys online, which were ethically approved by the Ethics Review Committee. The study employed validated tools to measure ADHD symptoms, emotion regulation, and empathy, ensuring that participants had a clear understanding of their status regarding ADHD criteria.
Study 1 Findings
The initial findings highlighted that out of 356 individuals who began the survey, 70% completed the initial baseline questionnaires. The emotional regulation metrics such as cognitive reappraisal indicated a significant improvement attributable to time. However, there were no substantial differences in the improvements among the various groups, emphasizing a potential benefit of MD over time that was primarily reflected in emotional suppression. These observed enhancements suggest that microdosing could be beneficial for individuals struggling with severe emotional regulation issues.
Comparative Analysis in Study 2
In a subsequent evaluation, the researchers compared individuals who underwent MD with those who consistently used conventional ADHD medication. Those who microdosed showed reduced ADHD symptoms more significantly than the control group after four weeks. Although the improvement in expressive suppression remained, the anticipations for benefits on cognitive reappraisal and empathy were unmet, signaling the necessity for additional investigations into microdosing’s long-term impacts on empathy.
Discussion and Limitations
The work highlights the positive influence of microdosing on reducing ADHD symptoms and improving emotional regulation, suggesting a potential modulation of serotonin mechanisms that may contribute to better emotional management. Nonetheless, the study acknowledges limitations related to its observational nature, as factors such as substance type and self-reported diagnoses may impact results. Further exploration in more controlled environments could yield a deeper understanding of microdosing’s comprehensive effects on both ADHD and emotional regulation across different contexts.
Conclusion
The findings from this study suggest that microdosing could serve as a valuable option for individuals with severe ADHD symptoms, primarily affecting emotional regulation more favorably than traditional treatment routes. However, more rigorous studies are required to bolster evidence surrounding its long-term effects on empathy and overall emotional health.
Read the full paper summary on Blossom.
